Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 21
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Gene Ther ; 14(6): 533-44, 2007 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17109009

RESUMEN

The immunogenicity of recombinant adenoviruses (Ad) constitutes a major concern for their use in gene therapy. Antibody- and cell-mediated immune responses triggered by adenoviral vectors hamper long-term transgene expression and efficient viral readministration. We previously reported that interleukin (IL)-6 and tumor necrosis factor (TNF)-alpha play an essential role in both the acute phase and antibody response against Ad, respectively. As TNF-alpha controls the immune response and the development of the immune system, we examined here the consequence of blockade of TNF-alpha activity through Ad-mediated gene delivery of a dimeric mouse TNFR1-IgG fusion protein on transgene expression from a second Ad. Ad encoding TNFR1-IgG (AdTNFR1-Ig) was injected intravenously along with Ad encoding beta-galactosidase or alpha1-antitrypsin transgene in wild-type (IL-6(+/+)) but also in IL-6-deficient mice (IL-6(-/-)) to analyze how TNF-alpha and IL-6 diminish liver gene transfer efficacy. Blockade of TNF-alpha leads to increased transgene expression in both wild-type and IL-6(-/-) mice due to a reduced inflammatory response and to diminished recruitment of macrophages and NK cells towards the liver. Antibody responses against adenoviral particles and expressed transgenes were only delayed in AdTNFR1-Ig-treated wild-type mice, but were markedly reduced in AdTNFR1-Ig-treated IL-6(-/-) mice. Finally, treatment of mice with etanercept, a clinically approved anti-TNF-alpha drug, confirmed the importance of controlling proinflammatory cytokines during gene therapy by adenoviral vectors.


Asunto(s)
Infecciones por Adenoviridae/inmunología , Adenoviridae/genética , Terapia Genética/métodos , Interleucina-6/inmunología , Transducción Genética/métodos , Factor de Necrosis Tumoral alfa/inmunología , Adenoviridae/inmunología , Animales , Anticuerpos Antivirales/sangre , Autoanticuerpos/sangre , ADN Viral/genética , Etanercept , Expresión Génica , Vectores Genéticos/administración & dosificación , Vectores Genéticos/genética , Hepatitis/inmunología , Humanos , Inmunoglobulina G/uso terapéutico , Ratones , Ratones Endogámicos BALB C , Ratones Noqueados , ARN Mensajero/análisis , Receptores del Factor de Necrosis Tumoral/uso terapéutico , Receptores Tipo I de Factores de Necrosis Tumoral/inmunología , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Transgenes , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores
2.
J Rheumatol ; 28(5): 956-61, 2001 May.
Artículo en Inglés | MEDLINE | ID: mdl-11361222

RESUMEN

OBJECTIVE: To determine whether overexpression of the Fas ligand (FasL) on activated lpr T lymphocytes could induce arthritic lesions when grafted into syngeneic wild-type MRL mice expressing normal Fas receptor levels. METHODS: Lethally irradiated MRL+/+ mice were reconstituted with congenic MRL/lpr bone marrow cells and splenocytes overexpressing FasL. Fas-mediated cytotoxic properties of repopulating lpr splenic lymphocytes were evaluated in vitro. Simultaneously, the hind paw ankles of the hematopoietic chimeras were histologically examined. RESULTS: The lpr lymphocytes repopulating the spleen overexpressed FasL and had in vitro Fas-mediated cytotoxic activity. Simultaneously, in vivo, articular (synovitis, pannus) and periarticular (periostitis) inflammation with bone resorption were observed. CONCLUSION: Arthritic lesions may be induced in Fas-expressing recipients by persistent engrafted syngeneic lymphocytes overexpressing FasL.


Asunto(s)
Artritis Reumatoide/inmunología , Enfermedad Injerto contra Huésped/inmunología , Glicoproteínas de Membrana/inmunología , Quimera por Trasplante/inmunología , Animales , Articulación del Tobillo/patología , Apoptosis/inmunología , Artritis Reumatoide/patología , Pruebas Inmunológicas de Citotoxicidad , Proteína Ligando Fas , Hepatocitos/inmunología , Hepatocitos/patología , Hígado/citología , Hígado/inmunología , Ratones , Ratones Endogámicos MRL lpr , Periostitis/inmunología , Periostitis/patología , Bazo/citología , Bazo/inmunología , Bazo/trasplante , Linfocitos T/inmunología , Linfocitos T/trasplante
3.
J Gene Med ; 2(5): 344-52, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-11045428

RESUMEN

BACKGROUND: Nitric oxide (NO), produced by NO synthase II (NOS II), is the main mediator of the tumoricidal action of activated macrophages. In the present study we examined the potential of the NOS II gene as a suicide gene for medullary thyroid cancer (MTC) therapy. METHODS: We orthotopically transplanted rMTC 6-23 cells into the inbred strain of Wag/Rij rats and constructed a plasmid carrying the NOS II gene under the control of the cytomegalovirus (CMV) promoter. RESULTS: Successive injections of tumor cells (Day 0) and naked DNA (Day 2) caused strong inhibition of tumor growth (50%, p < 0.05). Plasmid injection into established tumors (14-day tumors) resulted in the development of large cavities due to tumor cell destruction, with a significant reduction in tumor tissue volume (35%, p < 0.05). Adjacent quiescent tissues were unaffected. Cell death occurred by apoptosis as demonstrated by specific labeling. Macrophages and CD4+ lymphocytes were recruited in the treated tumors. However, tumor-specific T lymphocytes were undetectable in the spleen of treated rats. In control experiments using Lac Z as a reporter gene, expression of beta-galactosidase was detected in only 1% of the tumor cells. CONCLUSIONS: Despite a low gene transfer efficiency, NOS II plasmid produced a strong anti-tumor action resulting from its marked 'bystander' effect mainly due to NO production and diffusion. Therefore the NOS II gene appears to be a promising suicide gene therapy of human cancer.


Asunto(s)
Terapia Genética/métodos , Óxido Nítrico Sintasa/genética , Neoplasias de la Tiroides/terapia , Animales , División Celular/efectos de los fármacos , Citotoxicidad Inmunológica , ADN Recombinante/administración & dosificación , ADN Recombinante/genética , Técnicas de Transferencia de Gen , Humanos , Operón Lac , Trasplante de Neoplasias , Óxido Nítrico/metabolismo , Donantes de Óxido Nítrico/farmacología , Óxido Nítrico Sintasa de Tipo II , Penicilamina/análogos & derivados , Penicilamina/farmacología , Plásmidos/administración & dosificación , Plásmidos/genética , Ratas , Ratas Endogámicas , Neoplasias de la Tiroides/patología , Neoplasias de la Tiroides/fisiopatología , Células Tumorales Cultivadas
4.
Blood ; 94(3): 1028-37, 1999 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-10419895

RESUMEN

In the immunosuppression accompanying the lethal systemic graft-versus-host reaction (GVHR) directed against minor histocompatibility antigens in irradiated adult mice, we previously determined that non-T, non-B, L-leucine methyl ester (LME)-sensitive cells were implicated via two different mechanisms: one, which is interferon-gamma (IFN-gamma)-dependent and affects both T-cell proliferative responses and thymus-independent antibody production by CD5(+) B cells; and a second, which is IFN-gamma-independent and affects B-cell proliferative responses. Because IFN-gamma induces the production of nitric oxide (NO), a potent immunosuppressive molecule, we investigated the involvement of NO in the suppression mediated by the LME-sensitive cells. Inducible NO synthase (iNOS) mRNA, iNOS protein, and the stable end products of iNOS pathway, L-citrulline and nitrite, were detected early in GVHR in LME-sensitive spleen cells taken ex vivo and could be amplified in vitro by T and B mitogens. Inhibition of NO production with arginine analogs (aminoguanidine, N(G)-monomethyl-L-arginine [LMMA]), like anti-IFN-gamma antibodies, reversed suppression of both T-cell responses to concanavalin A and CD5(+) B-cell responses, but not of B-cell response to lipopolysaccharides (LPS). The GVHR-associated, IFN-gamma-dependent immunosuppression of T-cell proliferation and of antibody synthesis by CD5(+) B cells is the consequence of NO production by LME-sensitive cells. Immunohistochemical analyses indicate that these cells belong to the macrophage lineage.


Asunto(s)
Reacción Injerto-Huésped/inmunología , Terapia de Inmunosupresión , Óxido Nítrico/inmunología , Animales , Inhibidores Enzimáticos/farmacología , Interferón gamma/inmunología , Ratones , Antígenos de Histocompatibilidad Menor/inmunología , Óxido Nítrico Sintasa/antagonistas & inhibidores , Óxido Nítrico Sintasa/inmunología , Óxido Nítrico Sintasa de Tipo II
5.
J Immunol ; 159(9): 4197-204, 1997 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-9379013

RESUMEN

Fas is an apoptosis-signaling receptor that triggers cell death upon binding to its ligand (FasL). Autoimmune-prone MRL/lpr mice, characterized by a spontaneous mutation of Fas, exhibit a defect in the activation-induced cell death of mature T cells through a Fas-mediated pathway. As a consequence of this defect, activated T cells accumulating in this strain overexpress the FasL and can therefore mediate in vitro Fas-dependent cytotoxicity. To determine whether hepatic injury could be the result of an interaction between T lymphocytes bearing FasL and Fas-expressing liver cells, the livers of lethally irradiated MRL+/+ recipients reconstituted with MRL/lpr lymphoid cells were studied. After transfer of MRL/lpr spleen cells, livers were infiltrated by polyclonal CD8+ T lymphocytes of lpr origin with a peak on day 21 postgrafting. These donor-derived intrahepatic lymphocytes overexpressed the FasL and exerted in vitro Fas-mediated cytotoxicity against Fas+ thymocytes, which was specifically inhibited by soluble recombinant Fas in a dose-dependent manner. These intrahepatic lymphocytes induced apoptosis in vitro, irrespective of MHC restriction, in Fas-expressing primary cultured hepatocytes. Histologic examination of the liver revealed severe endothelialitis as well as periportal and intralobular infiltrations of activated lymphocytes with apoptotic hepatocytes in their vicinity. Simultaneously, liver damage was ascertained by elevated serum transaminase levels. These observations support the notion that an Ag-independent mechanism involving FasL may play a role in certain liver pathologies.


Asunto(s)
Apoptosis/inmunología , Enfermedad Injerto contra Huésped/inmunología , Hematopoyesis/inmunología , Trasplante de Células Madre Hematopoyéticas , Hígado/patología , Receptor fas/inmunología , Animales , Enfermedad Injerto contra Huésped/patología , Hematopoyesis/genética , Hígado/inmunología , Ratones , Ratones Endogámicos MRL lpr , Quimera por Trasplante
6.
Eur J Immunol ; 27(2): 415-20, 1997 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-9045912

RESUMEN

Autoimmune-prone MRL/lpr mice, homozygous for the lpr mutation, exhibit defective apoptosis and develop generalized lymphoproliferation with the accumulation of a double-negative (DN: CD4- CD8-) T cell population. The capacity of lpr T lymphocytes to effectuate Fas- and perforin-mediated cytotoxicity was investigated. Spleen and lymph nodes cells spontaneously lyse Fas- targets (thymocytes) through a Fas-mediated mechanism as a consequence of their overexpression of Fas ligand (FasL) confirmed by semiquantitative reverse transcription (RT)-PCR and immunoprecipitation analysis. This cytotoxicity was greatly increased after stimulation of the effectors by phorbol myristate acetate (PMA) + ionomycin. Under these conditions, MRL/lpr spleen and LN cells exhibited strong Fas-mediated Ca2+-independent cytotoxic activity against wild-type Fas+ (H-2 compatible or incompatible) thymocytes or lipopolysaccharide (LPS)-transformed blast cells. Such Fas-mediated cytotoxic activity was also observed with C57BL/6-lpr, but never with wild-type C57BL/6 or MLR+/+ effectors. Depletion experiments showed that the effector cells of this Fas-mediated cytotoxicity were DN T cells. This subset, which represent in vivo activated T cells, can spontaneously lyse Fas+ targets by a mechanism that does not need the interaction of the T cell receptor (TCR) with major histocompatibility complex molecule plus antigen. This lytic potential is increased by PMA + ionomycin, which sends a second activation signal to these primed T cells. Therefore, the small amounts of Fas receptor expressed on MRL/lpr tissues may account for their nonspecific autoimmune attack by DN cells. In Con A-containing medium, which allows detection of the perforin-mediated pathway against Fas targets, cytotoxic CD8+ effectors were detected that are able to kill lpr thymocytes via a Ca2+-dependent pathway. Thus, in MRL/lpr mice, these CD8+ cells could constitute potent cytotoxic effectors against cells presenting antigen to their TCR.


Asunto(s)
Antígenos CD4/análisis , Antígenos CD8/análisis , Citotoxicidad Inmunológica/inmunología , Glicoproteínas de Membrana/inmunología , Subgrupos de Linfocitos T/inmunología , Linfocitos T Citotóxicos/inmunología , Receptor fas/inmunología , Animales , Células Cultivadas , Concanavalina A/análisis , Medios de Cultivo/química , Proteína Ligando Fas , Ionomicina/análisis , Ligandos , Glicoproteínas de Membrana/biosíntesis , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos DBA , Ratones Endogámicos MRL lpr , Perforina , Proteínas Citotóxicas Formadoras de Poros , Linfocitos T Citotóxicos/metabolismo , Acetato de Tetradecanoilforbol/análisis
7.
J Interferon Cytokine Res ; 15(4): 351-7, 1995 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-7627810

RESUMEN

Of the growth-promoting factors, transforming growth factor beta (TGF-beta) has been most clearly shown to act as a potent regulator of inflammation and immunity. It is highly suppressive for T and B lymphocyte proliferation, cytotoxic T lymphocyte generation, and lymphokine-activated killer cell development, as well as natural killer cell activity. Moreover, there is accumulating evidence that TGF-beta also may contribute to impaired immune surveillance of tumor development. In previous work, we isolated and described a 40 kD glycoprotein extracted from mouse placenta. This placental factor (PF) is also a potent immune modulator in vivo: it is highly inhibitory of secondary antibody responses as well as cellular responses, such as local graft-versus-host reactions. Because placenta has been shown to be a major source of TGF-beta and several reports have indicated an important role for TGF-beta in the immunosuppressive mechanisms taking place during the course of mammalian gestation, we have looked for the presence of TGF-beta in our placental factor preparations. Our results clearly indicate that they do not contain TGF-beta or TGF-beta-like molecules by the following criteria: (1) no inhibition of Mv-1 Lu cell proliferation at any dose tested; (2) no band detected by immunoblotting using different polyclonal reagents specific for TGF-beta 1; and (3) no activity retained on or eluted from an affinity column made of immobilized monoclonal antibody against TGF-beta 2. Aliquots of the same preparations retained their full immune inhibitory capacity in vivo throughout the various assays.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Inmunosupresores/análisis , Intercambio Materno-Fetal , Placenta/química , Factor de Crecimiento Transformador beta/análisis , Animales , Anticuerpos Monoclonales , División Celular/efectos de los fármacos , Línea Celular , Cromatografía de Afinidad , Femenino , Immunoblotting , Ratones , Ratones Endogámicos CBA , Embarazo , Factor de Crecimiento Transformador beta/inmunología
8.
J Biol Chem ; 269(34): 21891-7, 1994 Aug 26.
Artículo en Inglés | MEDLINE | ID: mdl-7520445

RESUMEN

Nitric oxide (NO) synthesized by macrophages inhibits tumor cell replication. NO also inhibits ribonucleotide reductase, an enzyme essential for DNA synthesis, probably by quenching the catalytically active tyrosyl free radical of its R2 subunit. The role of this inhibition in NO-mediated cytostasis was thus evaluated. After a 4-h coculture with macrophages, quenching of the radical was demonstrated by electron paramagnetic resonance spectroscopy in transfected L1210-R2 cells over-expressing the R2 protein. Pronounced cytostasis was simultaneously observed. A NO synthase inhibitor greatly reduced both phenomena. Target cells withdrawn from macrophages partially recovered from cytostasis and radical loss within 90 min. Deoxyribonucleosides added to by-pass ribonucleotide reductase inhibition efficiently reversed cytostasis of K-562 cells. After a 24-h coculture, the quenched tyrosyl radical still reappeared in L1210-R2 cells withdrawn from macrophages, but DNA synthesis did not resume. Moreover, deoxyribonucleosides marginally reversed overnight cytostasis of K-562 cells mediated by macrophages but were efficient against cytostasis induced by hydroxyurea, a ribonucleotide reductase inhibitor. Autocrine cytostasis observed early in TA3-H2 cells committed to produce NO was closely correlated with quenching of the tyrosyl radical but not with formation of dinitrosyl-iron complexes. We thus propose that NO-dependent cytostasis begins with a rapid and reversible inhibition of ribonucleotide reductase, progressively reinforced by other, long-lasting antiproliferative effects.


Asunto(s)
Antineoplásicos/metabolismo , Macrófagos/metabolismo , Óxido Nítrico/metabolismo , Ribonucleótido Reductasas/metabolismo , Tirosina/química , Aminoácido Oxidorreductasas/antagonistas & inhibidores , Animales , Antineoplásicos/química , Carcinoma/metabolismo , Desoxirribonucleósidos/farmacología , Espectroscopía de Resonancia por Spin del Electrón , Radicales Libres , Leucemia L1210/metabolismo , Óxido Nítrico/química , Óxido Nítrico Sintasa , Proteínas Recombinantes/química , Proteínas Recombinantes/metabolismo , Ribonucleótido Reductasas/química , Ribonucleótido Reductasas/genética , Células Tumorales Cultivadas
9.
Scand J Immunol ; 39(2): 157-64, 1994 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-8296158

RESUMEN

The authors have a long standing interest in immune regulations which control the absence of rejection of a semi-allogeneic fetus by the mother. A previous work described a soluble 40 kDa factor extracted from mouse placenta and capable of inhibiting secondary immune responses in vitro. The present paper reports the following on its mode of action in vivo: (1) it is active even in a fully allogeneic host; (2) it can be administered i.v. or i.p. along with antigen; and (3) the injections of factor and antigen must not be more than 2 days apart for maximum efficacy. Moreover, the results of the study described here indicate also that this factor is a concanavalin A-binding glycoprotein, sensitive to heat and pronase, and different from interleukin 10 (IL-10). Thus, this placental factor appears to be different from previously described immune regulators such as IL-10 and could contribute significantly to immune regulations at the level of the placenta.


Asunto(s)
Tolerancia Inmunológica , Factores Inmunológicos/inmunología , Placenta/inmunología , Animales , Concanavalina A/farmacología , Femenino , Concentración de Iones de Hidrógeno , Factores Inmunológicos/administración & dosificación , Interleucina-10/análisis , Complejo Mayor de Histocompatibilidad , Ratones , Ratones Endogámicos , Temperatura , Factores de Tiempo
10.
J Immunol ; 151(5): 2813-9, 1993 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-7689616

RESUMEN

In some aged MRL/Ipr autoimmune disease-prone mice, unexpected reactivity has been observed between lymphoid cells and mAb or polyclonal antibodies directed against the A beta d class II chain of the MHC. However, Southern blot analysis of their genomic DNA, using different class I and class II MHC-specific probes, confirmed their inbred character and their H-2k genotype. In this study, immunoprecipitation experiments with an anti-A beta d mAb indicated that the 45 (and 12)-kD molecule(s) recognized by an anti-A beta d mAb differed from a class II chain. After specific antibody screening of a lambda gt11 expression library constructed with MRL/Ipr "A beta d-positive" lymphoid cells, we cloned cDNA that share sequences with high homology (> 80%) to the 3' end of a 7-kb L1Md (L1) element propagated in the mouse genome via retrotransposition. Northern blot analysis showed an overtranscription of these L1 sequences in the MRL/Ipr spleen cells used for the construction of the cDNA library, in comparison to the MRL ancestor strains. Therefore, the autoimmune MRL/Ipr strain could express a translation product of L1 open reading frame 2, which mimics a "highly antigenic" epitope of an allogenic MHC class II Ag.


Asunto(s)
Enfermedades Autoinmunes/inmunología , Elementos Transponibles de ADN , Epítopos/genética , Antígenos de Histocompatibilidad Clase II/inmunología , Trastornos Linfoproliferativos/inmunología , Animales , Enfermedades Autoinmunes/genética , Secuencia de Bases , ADN/química , ADN/aislamiento & purificación , Trastornos Linfoproliferativos/genética , Ratones , Ratones Endogámicos , Pruebas de Precipitina , ARN Mensajero/análisis
11.
Am J Clin Pathol ; 99(3): 257-60, 1993 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-8383421

RESUMEN

Wilms' tumors (nephroblastomas) are heterogeneous tumors consisting of proliferating epithelial cells in glomeruloid bodies and tubule formations and of proliferating blastemal cells. Using a specific CR1 35S-labeled cDNA probe and CR1 antibodies, CR1 mRNA and CR1 antigen-expressing cells were detected in glomeruloid bodies in one case of Wilm's tumor. The concomitant expression of CR1 mRNA and CR1 antigen and the high level of CR1 mRNA expression that characterize podocytes at an early stage of glomerular maturation in the normal human fetal kidneys indicates that glomeruloid bodies are composed of immature podocytes.


Asunto(s)
Glomérulos Renales/metabolismo , Neoplasias Renales/metabolismo , ARN Mensajero/análisis , Receptores de Complemento 3b/análisis , Tumor de Wilms/metabolismo , Sondas de ADN , Humanos , Procesamiento de Imagen Asistido por Computador , Técnicas para Inmunoenzimas , Hibridación in Situ , Neoplasias Renales/genética , Receptores de Complemento 3b/genética , Tumor de Wilms/genética
12.
Eur J Immunogenet ; 18(5-6): 355-65, 1991.
Artículo en Inglés | MEDLINE | ID: mdl-1772880

RESUMEN

Cell lines and a clone established from the C57BL/6 (H-2b) Lewis lung (3LL) tumour were previously characterized with respect to tumour growth and metastatic spread in vivo, and to the expression of a 3LL tumour-specific antigen (3LL TA) using a monoclonal antibody raised in syngeneic mice immunized with 3LL cells. No correlation was observed between the presence of 3LL TA and the prevention of metastatic spread which suggests that the immune recognition of this tumour antigen requires the presence of a self H-2 molecule absent from these tumour cells. Indeed, radioimmunoassay (RIA) and cytofluorometric analysis using specific monoclonal antibodies have shown that the H-2Kb molecule was not expressed at the cell surface of all 3LL cell lines and clones, while the H-2Db molecule was present at normal levels. This defect, which was not the consequence of a lack of beta 2m expression, was accompanied by an absence or a marked reduction of the H-2K mRNA level (which has been reversed in the M4 cell line by in vitro gamma interferon treatment), while the H-2D class I gene was normally transcribed. Another defective transcription was also observed for a gene in the Tla region (gene 37). This low '37' phenotype was corrected by in vitro treatment of the M4 cell line with gamma interferon, which indicates that this class I gene of the Qa/Tla region has an interferon response sequence in the promoter.


Asunto(s)
Antígenos H-2/inmunología , Antígenos de Histocompatibilidad Clase I/inmunología , Animales , Anticuerpos Monoclonales , Secuencia de Bases , Northern Blotting , Expresión Génica , Genes MHC Clase I , Antígenos H-2/genética , Antígenos de Histocompatibilidad Clase I/genética , Técnicas In Vitro , Interferón gamma/farmacología , Ratones , Datos de Secuencia Molecular , Sondas de Oligonucleótidos/química , Proteínas Recombinantes , Células Tumorales Cultivadas , Microglobulina beta-2/genética
13.
J Immunogenet ; 16(3): 223-31, 1989 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-2614072

RESUMEN

CBA/J (H-2k) females, mated with DBA/2 J (H-2d) or DBA/1 J (H-2q) males, exhibit a high rate of fetal resorption. In contrast, when H-2 identical CBA substrains (i.e. CBA/Ca and CBA/N) are used, this phenomenon is not observed. On the other hand, before mating with DBA/2 J males, pre-immunization of CBA/J females with spleen cells coming from BALB/c J or (DBA/2 x BALB/c J) F1 males (and not from other H-2d identical males whatever their Mls alleles) has significantly decreased the fetal resorption rate. Thus, immunization against determinants other than classical H-2d (K, I, D, L) antigens (transmitted as a dominant character and different from Mls determinants) can elicit anti-abortive effects. Furthermore, it was observed that the spleen cell endowed with the anti-abortive effects was neither a T nor a B lymphocyte. In contrast, peritoneal cells were able to reproduce the phenomenon, indicating that it may be mediated by a cell of the macrophage-monocyte lineage. Finally, a first gestation was substituted for allo-immunization of CBA/J females. The anti-abortive effects of a first pregnancy by BALB/c J males (and not by other H-2k syngeneic or H-2d allogeneic males) was observed in the course of a second pregnancy sired by DBA/2 J males. These data can be interpreted in terms of maternal recognition of an antigen present on both macrophages and trophoblast cells and necessary for a successful gestation, which is coded for by genes outside the K, I, D, L regions.


Asunto(s)
Aborto Veterinario/inmunología , Muerte Fetal/inmunología , Reabsorción del Feto/inmunología , Ratones Endogámicos CBA/inmunología , Ratones Endogámicos DBA/inmunología , Aborto Veterinario/prevención & control , Animales , Cruzamientos Genéticos , Femenino , Antígenos de Histocompatibilidad/inmunología , Inmunización/veterinaria , Masculino , Ratones , Ratones Endogámicos BALB C , Cavidad Peritoneal/citología , Embarazo , Mantenimiento del Embarazo/inmunología , Bazo/inmunología
14.
Scand J Immunol ; 28(6): 705-17, 1988 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-2466325

RESUMEN

We have previously shown that two distinct mouse placental fractions (PF) are potent immunomodulators in vivo. A 40 kDa PF induces a marked decrease of plaque forming cell (PFC) responses, while a 60 kDa PF increases them. Both effects are specific for the priming antigen. In the present study, these two PF are assayed on a cell-mediated response to allogeneic cells, i.e. in a local graft-versus-host reaction (LGVHR). Mice were primed with allogeneic cells in the presence of various amounts of the 40 kDa or 60 kDa PF, or liver extract (LE) as control. Six days later, their spleen cells were injected into the footpads of F1 recipients. Precise dose-response curves were established and the kinetics of the GVH response were carefully followed. Parallel with the modulation of PFC responses, the 40 kDa PF caused a potent inhibition of the LGVHR, while the 60 kDa PF greatly enhanced it. Both effects were specific for the alloantigens injected with the PF. Furthermore, we showed that these modulations were observed whatever the intensity of the GVH reaction, which varied according to the number of primed spleen cells transferred. This report also demonstrates that these PF can be greatly enriched by passage over affinity columns made of insolubilized lectins. The 40 kDa PF is retained on and can be eluted from columns of insolubilized concanavalin A (Con A) or wheat germ agglutinin (WGA), which indicates that it is a glycoprotein. Conversely, the 60 kDa PF does not bind to any of the above lectins and is probably not a glycoprotein. This biochemical purification step is also a good procedure for obtaining an even cleaner separation of the two fractions from each other. Thus, this paper demonstrates that both PF have important regulatory properties on specific cellular immune responses.


Asunto(s)
Adyuvantes Inmunológicos/administración & dosificación , Epítopos/inmunología , Reacción Injerto-Huésped/efectos de los fármacos , Proteínas Gestacionales/administración & dosificación , Animales , Cromatografía de Afinidad , Relación Dosis-Respuesta Inmunológica , Epítopos/genética , Femenino , Lectinas , Extractos Hepáticos/administración & dosificación , Extractos Hepáticos/inmunología , Ratones , Ratones Endogámicos A , Ratones Endogámicos C57BL , Ratones Endogámicos CBA , Peso Molecular , Embarazo , Proteínas Gestacionales/inmunología , Especificidad de la Especie
15.
J Immunogenet ; 15(5-6): 307-19, 1988.
Artículo en Inglés | MEDLINE | ID: mdl-2475545

RESUMEN

During their ageing, MRL-lpr/lpr mice (H-2k) suffer from progressive lymph node enlargement, associated with the development of several acute autoimmune lesions. The primary effect and location of the lpr mutation is unknown. However, a minority of the lymphoid cells of some MRL-+/+, as well as MRL-lpr/lpr mice, express 'alien' H-2d antigenic specificities. In the course of the investigation of the origin of the latter, we have carried out the genotyping of the MHC of several MRL-+/+ and MRL-lpr/lpr mice using the Southern blotting technique and employing a variety of MHC class I and class II probes, and restriction enzymes known to discriminate between the d and the k haplotypes. None of the results obtained so far suggests the contribution of genuine H-2d genes to the MHC of the MRL-+/+ and MRL-lpr/lpr mouse strains. Alternative hypotheses for the generation of the 'alien' epitopes are discussed.


Asunto(s)
Complejo Mayor de Histocompatibilidad , Ratones Mutantes/inmunología , Animales , Enfermedades Autoinmunes/genética , Enfermedades Autoinmunes/inmunología , Epítopos/genética , Genes MHC Clase I , Genes MHC Clase II , Genotipo , Antígenos H-2/genética , Ratones , Ratones Mutantes/genética , Polimorfismo de Longitud del Fragmento de Restricción
16.
Immunogenetics ; 25(4): 251-7, 1987.
Artículo en Inglés | MEDLINE | ID: mdl-3494673

RESUMEN

The MRL/lpr (H-2k) inbred strain, a model for the autoimmune disease systemic lupus erythematosus, differs from the healthy inbred strain MRL +/+ (H-2k) by only 0.1% of its genome. Southern blot analysis using class I and class II probes confirmed the H-2k genotype of both strains. Among the Iak-positive peritoneal cells, cells with an unexpected expression of Iad specificities were detected in a radioimmunoassay using several monoclonal antibodies and one conventional antiserum. This was only found in aged (6- to 9-month-old) mice both in the MRL/lpr strain (32% Iad-positive mice) and in the MRL +/+ strain (42% Iad-positive mice). Furthermore, 24% of aged MRL/lpr mice exhibited strong spontaneous cytotoxic T lymphocyte (CTL) activities against P815 (H-2d) target cells, and 57% had a weaker but still detectable level of cytotoxicity. In contrast, such a CTL activity has never been found in the MRL +/+ strain. These results suggest that the anti-H-2d CTL plays a role in the onset of the autoimmune process in MRL/lpr mice.


Asunto(s)
Enfermedades Autoinmunes/inmunología , Citotoxicidad Inmunológica , Antígenos H-2/inmunología , Animales , Anticuerpos Monoclonales/inmunología , Autoantígenos/inmunología , Enfermedades Autoinmunes/genética , Antígenos H-2/genética , Haplotipos , Lupus Eritematoso Sistémico/genética , Lupus Eritematoso Sistémico/inmunología , Ratones , Ratones Mutantes , Linfocitos T Citotóxicos/inmunología
17.
Nephrologie ; 8(3): 147-53, 1987.
Artículo en Inglés | MEDLINE | ID: mdl-3658091

RESUMEN

CBA/N (Xid) mice classically present a genetically determined immune deficiency. This is characterized by the absence of certain B lymphocyte subpopulations (Lyb 3, 5, 7) and a hyporeactivity towards class II T independent antigens. These mice were examined in comparison with conventional CBA/Ca (H-2k) histocompatible controls for their immune reactivity, using different systems linked to allogenic transplantation: the local graft-versus-host reaction (LGVHR), allogeneic tumor (Sa 1 A/J) rejection, mixed lymphocyte reaction (MLR) and cell mediated lymphocytotoxicity (CML). It is concluded that a difference in reactivity is also present in some responses to classically T dependent antigens. This difference can result either in an increased reaction in the case of a primary LGVHR or a decrease in the same but late secondary reaction. The rejection of a tumor allograft (Sa 1 A/J - H-2a) is delayed in the CBA/N (H-2k) substrain with respect to conventional CBA mice. Cell mediated lymphocytotoxicity (CML) does not seem to be affected by the Xid defect in immunized cell donors. On the contrary, MLR responses are strikingly increased. It is suggested that the poor seeding of B cells into peripheral lymphoid organs alters the T/B ratio, favoring either T effector cells or T suppressors (Ts) according to the models used. Antibody responses to allogeneic H-2 antigens are not significantly modified.


Asunto(s)
Reacción Injerto-Huésped , Ratones Endogámicos CBA/inmunología , Animales , Formación de Anticuerpos , Rechazo de Injerto , Inmunidad Celular , Activación de Linfocitos , Ratones , Trasplante de Neoplasias
18.
Cell Immunol ; 98(2): 477-85, 1986 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-2944618

RESUMEN

CBA/J females (H-2k) mated with DBA2/J males (H-2d) exhibit a high rate of fetal resorption. Fetal survival has been improved by pretreatment of CBA/J females with spleen cells from BALB/c J (H-2d) (but not from CBA/J or DBA/2/J) males. Similarly, three out of nine recombinant inbred strains (recombining BALB/c and DBA2 genomes at the homozygous state) possess antiabortive effects like the BALB/c parent. Previous studies showed that BALB/c pretreatment triggers the appearance of suppressor cells in the spleen and of IgG1 anti-H-2d antibodies in the serum of CBA/J females. Studies of these two immunological parameters after CBA/J preimmunization by the different recombinant strains suggest that local intrauterine immunoregulation is the determinant of success or failure of allopregnancy.


Asunto(s)
Aborto Veterinario/prevención & control , Aborto Veterinario/inmunología , Animales , Femenino , Antígenos H-2/inmunología , Tolerancia Inmunológica , Inmunoglobulina G/análisis , Inmunoterapia , Prueba de Cultivo Mixto de Linfocitos , Ratones , Ratones Endogámicos , Embarazo , Linfocitos T Citotóxicos/inmunología
19.
J Immunol ; 136(2): 574-81, 1986 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-2416814

RESUMEN

Previous results from our group had shown that when CBA mice are primed to sheep red blood cells (SRBC) in the presence of various doses of placental extract (PE) (or liver extract [LE] as control), their spleen cells injected into normal syngeneic recipients have important immunoregulatory properties. Low doses of PE (0.25 to 4 mg per mouse) induce a marked decrease of the PFC response against SRBC in recipient animals. In contrast, higher doses of PE (8 to 13 mg per mouse) have a potentiating effect on the same response. LE is not different from a saline injection, at any dose. The suppressive and enhancing effects can be reproduced with two distinct placental fractions (PF) of 40 KD and 60 KD, respectively. In the present report, we have studied the requirement for an antigenic stimulation at the same time as the injection of PE, and the antigenic specificity of the subsequent immunoregulatory effects. In addition, we have analyzed the functional properties of the spleen cell populations affected by PE or placental fractions: surface Ig- cells mediate the suppressive effect due to low doses of PE or the 40-KD fraction, whereas surface Ig+ cells are responsible for the enhancing effect due to high doses of PE or the 60-KD fraction. These immunoregulatory activities do not appear to be related to the presence of Ig fragments in PF, because our results have shown that no Ig fragments can be detected in either PF. Surface Ig- T cell populations from spleen cells treated with the 40-KD fraction and antigen have been further separated into Lyt-2- and Lyt-2+ subpopulations. Our results showed that Lyt-2+ cells alone suppress the PFC response anti-SRBC in both normal and irradiated syngeneic recipients. Thus, the injection of a 40-KD PF in the presence of antigen activates splenic T suppressor cells capable of specifically regulating a secondary antibody response in vivo.


Asunto(s)
Anticuerpos Heterófilos/biosíntesis , Linfocitos B/inmunología , Antígenos de Grupos Sanguíneos/inmunología , Proteínas Gestacionales/fisiología , Linfocitos T/inmunología , Adyuvantes Inmunológicos/administración & dosificación , Animales , Antígenos Ly , Linfocitos B/clasificación , Linfocitos B/efectos de la radiación , Relación Dosis-Respuesta Inmunológica , Epítopos/inmunología , Femenino , Técnica de Placa Hemolítica , Fragmentos de Inmunoglobulinas/aislamiento & purificación , Inmunosupresores/fisiología , Inyecciones Intraperitoneales , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Ratones Endogámicos CBA , Peso Molecular , Extractos Placentarios/administración & dosificación , Proteínas Gestacionales/análisis , Proteínas Gestacionales/inmunología , Ovinos , Especificidad de la Especie , Linfocitos T/clasificación , Linfocitos T/efectos de la radiación
20.
J Reprod Immunol ; 7(1): 27-39, 1985 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-3973852

RESUMEN

Modifications of the alloimmune response at both the humoral and the cellular levels by placental extracts (PE) syngeneic to the recipient were studied in the mouse using two different H-2 strain combinations. CBA (H-2k) or C57BL/Ks (H-2d), immunized with A/J (H-2a) spleen cells. The tests included in vivo tumor allograft evolution (accelerated rejection or enhancement reactions), and in vitro analysis of the involved immune agents, both cellular and humoral, using mixed lymphocyte reactions (MLR) and biological activity studies of serum samples. Animals from the recipient strains exhibited a delayed rejection of A/J tumor Sa 1 allografts if preimmunization was carried out with 10(6) A/J spleen cells combined with PE syngeneic to the recipients, as compared to controls immunized with A/J cells only or supplemented with isogeneic liver extracts (LE). The serological analysis revealed that PE treatment did not modify the overall hemagglutinating antibody production but resulted simultaneously in both a decreased production of cytotoxic complement fixing antibodies and an increase of specific anaphylactic mast cell degranulating antibodies, as compared to controls. The sera from PE-treated donors also demonstrated enhancing activity following passive transfer to isogeneic recipients. MLR regulatory activity was exhibited by spleen cells from PE- and immunogen-treated mice although the same or stronger activity was obtained from mice immunized without the addition of PE. However, in vivo transfer of these cells to syngeneic recipients showed that PE treatment erased the accelerated rejection caused by allogeneic immunization in the absence of PE and could even cause some degree of allografted tumor enhancement. The cells responsible for this inhibitory effect were mainly IJ+ lymphocytes, since their elimination with a relevant anti-IJ serum and complement restored a secondary type rejection pattern. These results show that PE present during the onset of immunization can promote the activation of regulatory agents such as enhancing antibodies and suppressor cells favoring allograft survival.


Asunto(s)
Tolerancia Inmunológica , Placenta/inmunología , Animales , Formación de Anticuerpos , Femenino , Supervivencia de Injerto , Inmunidad Celular , Inmunización , Técnicas In Vitro , Isoantígenos/inmunología , Ratones , Ratones Endogámicos , Embarazo , Bazo/inmunología , Trasplante Homólogo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA